200+ leading individuals in healthcare, life sciences and private equity gathered at the Shangri-La Hotel in Paris for the European Health & Life Sciences Symposium 2023 to enjoy a day packed with fireside chats, in-depth...more
11/28/2023
/ Artificial Intelligence ,
Capital Markets ,
Digital Health ,
EU ,
Healthcare ,
Information Technology ,
Investment ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Private Equity ,
Technology ,
UK
240+ leading individuals in healthcare, life sciences and private equity gathered at The Langham Hotel in central London for HPE Europe 2023 for a day packed with fireside chats, in-depth plenary sessions and an abundance of...more
A year ago, many stakeholders were apprehensive about the economic consequences of the COVID-19 health crisis, and no one knew whether it would affect private equity permanently. Despite the long-term crisis, activity in...more
9/1/2021
/ Capital Markets ,
Coronavirus/COVID-19 ,
Corporate Social Responsibility ,
Equity Markets ,
EU ,
France ,
Investment ,
Investors ,
Private Equity ,
Recovery Plans ,
Sustainability
Following the wider outbreak of the coronavirus (COVID-19) around the world, radical—and sometimes controversial—actions have been and are further expected to be taken by national, federal and local governments and...more
3/16/2020
/ Acquisitions ,
Business Interruption ,
Capital Markets ,
Commercial Insurance Policies ,
Contract Terms ,
Coronavirus/COVID-19 ,
Corporate Financing ,
Corporate Governance ,
Crisis Management ,
Debt Restructuring ,
Emergency Management Plans ,
Employer Responsibilities ,
Health Insurance ,
Healthcare Facilities ,
Life Sciences ,
Mergers ,
Portfolio Companies ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds ,
Regulatory Standards ,
Risk Assessment ,
Risk Mitigation ,
Supply Chain